Friday, September 30, 2022


Biotechnology News Magazine

Akadeum Life Sciences Announces New Dead Cell Removal Kit Using Microbubble Technology

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences—announces today the launch of their Dead Cell Removal Microbubble Kit (“DCR kit”).

This kit enables researchers to separate viable cells from dead cells, resulting in the elimination of the detrimental effects of these dead cells on transfection protocols, cell culture experiments, functional studies or single cell applications.

Akadeum Life Sciences DCR kit uses microbubbles, which offer researchers a more simplified and less cumbersome experience than conventional techniques by removing the need for costly and less-effective materials such as cartridges, magnetic columns or stand-alone instruments. When mixed in the sample, the microbubbles bind to the dead cells and then float them to the surface for removal, leaving behind a clean sample full of healthy cells.

“We have embraced the challenge of developing products that can meet the needs of researchers and address obstacles they currently face,” says Brandon McNaughton, PhD, CEO of Akadeum Life Sciences. “We believe our DCR kit will help researchers get to the results they seek efficiently and effectively.”

This revolutionary cell separation method is unlike other DCR kits because it effectively maintains a larger number of viable cells while removing the dead cells in a sample. In recent studies, Akadeum Life Sciences was able to retain over 85% of viable cells as compared to 20-40% from traditional DCR methods that use magnetic techniques. Additionally, Akadeum’s kit only requires about half the starting amount of cells as other methods due to its low rate of cell loss.

The benefits from the microbubble technology are vital for researchers, giving them more flexibility in types and numbers of experiments that can be performed. The Akadeum DCR kit was developed to meet the needs of researchers by providing them with more testable samples and time, improving the likelihood that they obtain the best possible results.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine